Faculty Opinions recommendation of Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients.

2018 ◽  
Author(s):  
Philip Rosenthal
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Renal Safety

Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients

2018 ◽  
Vol 47 (12) ◽  
pp. 1673-1681 ◽  
Author(s):  
H. J. Tsai ◽  
Y. W. Chuang ◽  
S. W. Lee ◽  
C. Y. Wu ◽  
H. Z. Yeh ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Renal Safety

Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease

2021 ◽  
Author(s):  
Hsin‐Ju Tsai ◽  
Ya‐Wen Chuang ◽  
Sheng‐Shun Yang ◽  
Yan‐Zin Chang ◽  
Horng‐Rong Chang ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Renal Safety

scholarly journals Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease

2015 ◽  
Vol 3 (2) ◽  
pp. 87-93
Author(s):  
Mohammad-Hossein Somi ◽  
Mohammad-Reza Ardalan ◽  
Majid Moghadaszadeh ◽  
Masoud Shirmohamadi ◽  
Reza Piri ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Hepatitis B ◽  
Hepatitis B Vaccination
Sign in / Sign up

Export Citation Format

Share Document